Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ross Callaway"'
Autor:
Ross Callaway, Ernest Duvall, Alfred A. Bartolucci, Lindy E. Harrell, Donna Kerns, Linda W. Duke, David G. Folks, Thomas J. Conboy
Publikováno v:
Archives of Neurology. 48:1136-1140
• In Alzheimer's disease (AD), the relationship between white-matter changes on magnetic resonance images and behavior are unclear. Therefore, magnetic resonance images, cognition, and psychiatric state were assessed in patients with AD with depres
Autor:
Thomas J. Conboy, Lindy E. Harrell, Ross Callaway, Kathleen A. Shay, Linda Warren Duke, David G. Folks
Publikováno v:
Journal of Geriatric Psychiatry and Neurology. 4:18-25
Considerable heterogeneity exists in the criteria used for the establishment of stages of impairment for patients with dementia. The valid distinction of stages is important both for clinical interpretation and the study of dementia. This study repor
Autor:
Janet C. Falgout, Ross Callaway, Carol Avery, Richard S. Jope, Mary Spiers, James H. Halsey, Lindy E. Harrell, Dano A. Leli, Donna A. Morere
Publikováno v:
Journal of the American Geriatrics Society. 38:113-122
To assess the efficacy of oral physostigmine for the treatment of Alzheimer's disease, 20 patients were entered into a clinical trial. All patients underwent a dose-finding phase (two weeks), followed by an open trial (two weeks), and a double-blind
Publikováno v:
Alzheimer disease and associated disorders. 7(2)
The frequency of occurrence of various types of dementing disorders has been ascertained primarily from autopsied series. Since autopsy is voluntary, it is unknown if these series are representative of the entire demented population. To assess this i
Publikováno v:
Neurology. 40(9)
We assessed the effect of chronic long-term physostigmine in 20 patients with probable Alzheimer's disease. Initially, all patients went through a dose-finding phase and a double-blind crossover period, and were subsequently classified as physostigmi
Publikováno v:
Alzheimer Disease & Associated Disorders. 5:50
We assessed the effect of chronic long-term physostigmine in 20 patients with probable Alzheimer9s disease. Initially, all patients went through a dose-finding phase and a double-blind crossover period, and were subsequently classified as physostigmi
Autor:
H. Ross Callaway
Publikováno v:
Scientific American. 80:399-400